PFPedro Vitor Soares Fonseca

Pedro Vitor Soares Fonseca

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pedro Vitor Soares Fonseca has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    BONE MARROW ASPIRATE IN SPINAL ARTHRODESIS: SYSTEMATIC REVIEW OF EFFICACY AND SAFETY

    by Anderson Matheus Medeiros DE Araújo, Marcus André Costa Ferreira, André Flávio Freire Pereira, Luciano Temporal Borges Cabral, Túlio Albuquerque DE Moura Rangel, Rodrigo Castro DE Medeiros, Dyego Luiz Pereira Lima DE Melo E Silva, Luiz Pedro Marques Gomes, Luis Menezes DA Fonseca Neto, Pedro Vitor Soares Fonseca, et al.

    Iliac Crest Bone Graft (ICBG) has historically been recognized as the gold standard in spinal arthrodesis procedures. However, its use is intrinsically associated with donor site complications, including chronic pain, paresthesia, risk of infection, and the limitation of available bone volume for harvesting. These disadvantages have motivated the exploration of biologically compatible and less invasive alternatives, such as Bone Marrow Aspirate (BMA). Although preliminary publications suggest favorable results, uncertainties persist regarding the actual effectiveness and safety of BMA in vertebral arthrodesis. Thus, the present study is a systematic review of the literature, conducted in accordance with the PRISMA Guidelines, whose primary objective was to evaluate the safety and clinical efficacy of BMA in spine arthrodesis procedures. The methodological quality of the identified Randomized Clinical Trials (RCTs) was assessed using the PEDro scale. The bibliographic search was performed by two independent reviewers in the Pubmed, Web Of Science, Scopus, and Embase databases, covering the period from 2005 to 2024. The descriptors “Bone Marrow Aspirate” OR “BMA” AND “Spine Fusion” OR “Spine Arthrodesis” were used, with the application of filters for “Randomized Controlled Trial,” “Meta-Analysis,” and “Systematic Reviews.” After screening and methodological evaluation, the final sample consisted of 14 studies. The consolidated data analysis demonstrated that BMA, notably when used in combination with synthetic grafts, presents satisfactory results concerning fusion rates, postoperative pain levels, and functional outcomes. These findings position BMA as a clinically viable alternative to ICBG. Level of Evidence II; Systematic Review.